Mechanisms of Disease: the link between RANKL and arthritic bone disease. - Wikidata - wikimedia - TriplyDB

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

http://www.wikidata.org/entity/Q36577375

about

Biology of RANK, RANKL, and osteoprotegerin New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways Interleukin 15 levels in serum may predict a severe disease course in patients with early arthritis Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.Biomarkers predicting a need for intensive treatment in patients with early arthritis Role of RANKL-RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications.Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis Using hand bone mass measurements to assess progression of rheumatoid arthritis.Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.Pathological role of osteoclast costimulation in arthritis-induced bone loss.The role of RANK ligand/osteoprotegerin in rheumatoid arthritis.Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study.Functions of RANKL/RANK/OPG in bone modeling and remodeling.Temporal differential effects of proinflammatory cytokines on osteoclastogenesis The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis Altered bone metabolism in inflammatory disease: role for nutrition.Cartilage homeostasis in health and rheumatic diseases.Sarilumab plus methotrexate suppresses circulating biomarkers of bone resorption and synovial damage in patients with rheumatoid arthritis and inadequate response to methotrexate: a biomarker study of MOBILITY Evidence that cytokines play a role in rheumatoid arthritis.Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.Protective effects of Fructus sophorae extract on collagen-induced arthritis in BALB/c mice.Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors.Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.Nuclear imaging of autoimmunity: focus on IBD and RA.Rheumatoid arthritis therapy: advances from bench to bedside.What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?Monoclonal antibody treatments for rheumatoid arthritis.The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?Apremilast for the treatment of psoriatic arthritis.

P2860

Q21195419-FBE70387-A81E-4B41-B933-1CF891C45021 Q22305855-894B2728-C124-45AA-B376-F5801D726405 Q24658507-62763115-0628-4984-B3DE-70E926F1F11F Q27687777-0E0BDBD5-B625-40A4-8258-63FADEA43A6D Q28088695-DC9C26D1-7FEC-4A9A-BC02-4285841FFBFE Q28533497-265B931D-E80F-4692-BB31-889225E45B9A Q28740658-0DE409FC-4324-4909-8914-04D89D7C5216 Q33706812-EAFDFC95-4729-4EAF-8FEE-D5DB79A31375 Q34982012-1C4CB1A7-AF2C-4F2A-8861-68C796A9D305 Q35165886-5FFA1F38-3373-4E4B-A0D7-D318AFD12938 Q35557836-8CA265F3-6BB6-4625-938E-B5AC94720136 Q35870458-0C5DBDE1-59CD-4F41-B8CA-AC1466FB00DD Q36059378-FB01C6C4-1D2B-448A-A14C-0EFF1AD8654A Q36065421-C23E8729-9972-44F4-B353-57FB6F675FE8 Q36090203-2A5BC07F-5B08-48BD-93BC-792B400CB56B Q36111285-7F9DCEB9-E79D-4452-8466-565B24B5AECE Q36134548-76EF4F83-A0FA-4122-8ED2-C63AAF5A8912 Q36246077-F44C7163-B262-4D52-BAE9-8674E7AA19BE Q36246148-BE1A4E78-C8C0-4404-B8ED-317D84C17649 Q36357390-65D40BB1-50C1-4F07-AC59-DF8F62F8D39D Q36470227-CFEC7188-AE6C-428D-8B95-6BC9CED93B4B Q36481786-CD393C06-2B34-4621-B6F7-B151451A568B Q36700779-F247DB6B-9EAF-4CB8-A574-77DD8CFD612B Q36753683-8AD89CD0-909F-4750-B56B-7401E390FFF9 Q36934993-3CC78363-8B52-4F46-97BA-AA3CC3ECEDE3 Q36939514-2C0BAD03-01BA-412A-A048-4110F183352B Q37138659-D35EBA7B-07F5-4306-A5C0-5ED88639A9DA Q37270714-A7535F05-B379-4AA3-B88A-9FE2ACD2164D Q37315782-C78D6DD7-68A5-4A19-A8D3-2AFDE527102D Q37316594-53C9B508-0FC2-4B00-A79E-F2D151654C4F Q37350853-A9E7A303-1496-42E2-875B-97B472E13A0D Q37594065-5FD4E9D5-4EED-4108-B298-ACE72672F116 Q37609095-4B710F19-42E1-4790-8D3E-CB6DF84D6967 Q37690607-96EA4621-975A-4916-A9C5-1BF3E4D96037 Q37730107-2D450E4D-511F-494B-B36A-21DE3A2969E5 Q37739480-5DA72ABB-4830-4A8B-BA10-FAE81B0A12F8 Q37842638-7DA9E0AE-0FAE-4AF3-9DCC-FADB0BE2B265 Q38116065-47CD7E90-2530-4299-A874-D6452BB662D7 Q38166991-4048AEE7-B145-4032-A140-3103F80C9342 Q38202205-F378C7AD-325C-470C-B86C-E02C6DD81920

P2860

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

http://www.wikidata.org/entity/Q36577375

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@ast

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@en

type

label

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@ast

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@en

prefLabel

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@ast

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@en

P1433

Q36577375-0C567F76-E98A-46B3-81A1-1800AFA03E5A

P1476

Q36577375-89468891-9947-4902-9964-FC0244DB29D7

P2093

Q36577375-0D86BE8C-9EAE-4552-9EBF-44847FA0D929

Q36577375-95E2C2D7-CBB9-4E4E-BBB2-1232CBA4D5C7

Q36577375-EC82F555-1A18-467F-BD1B-52395A1AF9FE

P2860

Q36577375-036FC712-205C-49C6-A88A-369CD1F6164A

Q36577375-094F9313-9917-4F18-9F97-9D6846252C6B

Q36577375-13BA4999-F319-4722-A960-9218C87B546C

Q36577375-1A19F505-7669-4048-8006-90EBCEF591C0

Q36577375-21FF4DCE-86C7-4DB4-84D0-0AA8F7094172

Q36577375-29BF8F2F-D292-4DA0-B5EA-80BC43205DBD

Q36577375-2F40D37F-A42C-4755-8695-649EA1BFEAED

Q36577375-308FF840-4119-4E2A-BE81-A4E8ABE1E264

Q36577375-36F210C6-FC1B-437F-8306-06EC87A12305

Q36577375-3CE5071F-A4F3-4A0C-BAB9-DE216E095C58

P304

Q36577375-1352E3E2-C9B1-4AB7-8619-25531930C28B

P31

Q36577375-5158BECF-938E-4D58-A916-A566899DB28D

P356

Q36577375-EC0F2188-642A-4283-A584-8E0380C1F53C

P433

Q36577375-A8BB61C7-587A-4E2E-899B-9027938BA669

P478

Q36577375-7EC22B6F-72D5-46E9-AC19-165DB34AAACF

P50

Q36577375-55F0397C-9EB7-48F2-B9BB-CAF499935A9A

Q36577375-8CDBA247-9002-4376-9774-0DEE8A8904F7

P577

Q36577375-F93E0F00-21C2-46AE-8920-DD744FF19744

P698

Q36577375-F18B39EA-0C6B-459F-AA34-E2A62A7AD505

P356

P1433

Nature Clinical Practice Rheumatology

P1476

Mechanisms of Disease: the link between RANKL and arthritic bone disease.

@en

P2093

Jochen Zwerina

http://www.w3.org/2001/XMLSchema#string

Kurt Redlich

http://www.w3.org/2001/XMLSchema#string

Silvia Hayer

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Bone resorption by osteoclasts

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis.

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.

P304

47-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPRHEUM0036

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16932627

http://www.w3.org/2001/XMLSchema#string